Avectas nets patent for cell engineering technology

By The Science Advisory Board staff writers

April 8, 2020 -- Avectas has received a patent for its Solupore cell engineering technology.

The U.S. Patent and Trademark Office issued U.S. patent No. 10,612,042, which covers the company's approach for delivering a payload, such as a protein or nucleic acid, across a plasma membrane of a cell.

Avectas is developing the delivery platform designed for the ex vivo manufacture of gene-modified cell therapy products. Its Solupore cell engineering technology is designed to overcome the challenges of manufacturing autologous and allogeneic cellular therapy products.

In March, Avectas announced a collaboration with Vycellix to develop technology for the optimized manufacture of cell and gene therapies. In February, Avectas signed a collaboration agreement with the Centre for Commercialization of Regenerative Medicine in Toronto to bring its Solupore nonviral cell engineering platform into the clinic.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here